🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02238106
The objective of this study is to investigate if the systemic drug exposure...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02254187
Treatments Being Tested
This efficacy and safety study compares four different combinations of blin...
Status
Completed
Location
1249.1.32003 Boehringer Ingelheim Investigational Site
Start Date
2007-10
Trial ID
NCT00535366
Treatments Being Tested
This is a PI-initiated study taking place only at UCLA, sponsored by Sunovi...
Status
Unknown
Location
UCLA
Start Date
2011-06
Trial ID
NCT01361984
Treatments Being Tested
This study investigated the effect of exercise and high-dose salbutamol on ...
Status
Completed
Location
Novartis Investigative site
Start Date
2007-08
Trial ID
NCT00531050
Treatments Being Tested
Asthma is a common, chronic respiratory disease affecting 1-18 percent of t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-01-18
Trial ID
NCT03376932
The primary objective of the study is to evaluate the long-term safety of f...
Status
Completed
Location
Teva Investigational Site 12068
Start Date
2014-07
Trial ID
NCT02175771
Treatments Being Tested
Each patient will participate in the study for approximately 7 weeks. Parti...
Status
Completed
Location
Teva Investigational Site 13178
Start Date
2015-05
Trial ID
NCT02437604
Treatments Being Tested
The purpose of this study is to optimise the device and/or formulation of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-16
Trial ID
NCT01540708
Treatments Being Tested
1. To compare the systemic drug exposure of 100 μg Serevent ® Diskus ® with...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT02254226
Treatments Being Tested